Benzinga's Top Upgrades

Analysts at Wells Fargo upgraded Allergan

from “market perform” to “outperform.” The target price range for Allergan has been raised from $99-$100 to $121-$122. Allergan's shares closed at $107.39 yesterday. CRT Capital upgraded Engility Holdings

from “fairly valued” to “buy.” The target price for Engility Holdings is set to $40. Engility Holdings' shares closed at $32.14 yesterday. Analysts at Wells Fargo upgraded Eagle Rock Energy Partners LP

from “market perform” to “outperform.” Eagle Rock Energy Partners' shares closed at $5.92 yesterday.